A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

The UMass Chan Medical School in Worcester announced Thursday it received a $35 million gift that aims to advance research to ...

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

Rodriguez is one of over a thousand people with speech difficulties who have cloned their voices using free software from ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Medicare Advantage plans are health insurance alternatives to Original Medicare, which provides health insurance to people ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic ...